Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.9 USD | -1.03% | -1.78% | -4.45% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Financials (USD)
Sales 2024 * | 530M | Sales 2025 * | 574M | Capitalization | 800M |
---|---|---|---|---|---|
Net income 2024 * | 38M | Net income 2025 * | 51M | EV / Sales 2024 * | 1.76 x |
Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.53 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
15.7
x | Employees | 3,600 |
Yield 2024 * |
0.23% | Yield 2025 * |
0.23% | Free-Float | 98.97% |
Latest transcript on Core Laboratories Inc.
1 day | +3.27% | ||
1 week | +0.47% | ||
Current month | -0.06% | ||
1 month | -0.47% | ||
3 months | +2.34% | ||
6 months | -25.20% | ||
Current year | -3.34% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 16.88 | -1.11% | 213 098 |
24-04-25 | 17.07 | +3.27% | 693,893 |
24-04-24 | 16.53 | -2.71% | 412,749 |
24-04-23 | 16.99 | +0.12% | 425,546 |
24-04-22 | 16.97 | -1.22% | 307,758 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.34% | 800M | |
+12.85% | 16.57B | |
0.00% | 6.78B | |
-14.58% | 2.8B | |
-14.78% | 2.61B | |
-33.16% | 1.69B | |
+7.06% | 1.28B | |
-8.04% | 1.05B | |
-7.98% | 858M | |
-12.45% | 779M |
- Stock Market
- Equities
- CLB Stock